Identification Generic Name (10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one DrugBank Accession Number DB07430 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one (DB07430) ×  Close Weight Average: 374.459  Monoisotopic: 374.120131908  Chemical Formula C 21 H 18 N 4 OS Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U MAP kinase-activated protein kinase 2 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as bipyridines and oligopyridines. These are organic compounds containing two pyridine rings linked to each other. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Pyridines and derivatives Sub Class Bipyridines and oligopyridines Direct Parent Bipyridines and oligopyridines Alternative Parents Thienodiazepines  /  Quinolines and derivatives  /  1-benzothiophenes  /  2-heteroaryl carboxamides  /  1,4-diazepines  /  Methylpyridines  /  Secondary alkylarylamines  /  Benzenoids  /  Vinylogous amides  /  Heteroaromatic compounds  /  Thiophenes  /  Lactams  /  Amino acids and derivatives  /  Secondary carboxylic acid amides  /  Azacyclic compounds  /  Organooxygen compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Organopnictogen compounds 
 
 
  show 9 more Substituents 1-benzothiophene  /  2-heteroaryl carboxamide  /  Amine  /  Amino acid or derivatives  /  Aromatic heteropolycyclic compound  /  Azacycle  /  Benzenoid  /  Benzothiophene  /  Bipyridine  /  Carboxamide group  /  Carboxylic acid derivative  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Lactam  /  Methylpyridine  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Para-diazepine  /  Quinoline  /  Secondary aliphatic/aromatic amine  /  Secondary amine  /  Secondary carboxylic acid amide  /  Thieno-para-diazepine  /  Thiophene  /  Vinylogous amide 
 
 
  show 19 more Molecular Framework Aromatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key CMWRPDHVGMHLSZ-GFCCVEGCSA-N InChI InChI=1S/C21H18N4OS/c1-11-3-4-13(10-22-11)15-6-5-14-16(25-15)7-8-17-18(14)19-20(27-17)21(26)24-12(2)9-23-19/h3-8,10,12,23H,9H2,1-2H3,(H,24,26)/t12-/m1/s1 IUPAC Name (15R)-15-methyl-5-(6-methylpyridin-3-yl)-11-thia-6,14,17-triazatetracyclo[8.8.0.0^{2,7}.0^{12,18}]octadeca-1(10),2(7),3,5,8,12(18)-hexaen-13-one SMILES [H][C@@]1(C)CNC2=C(SC3=C2C2=C(C=C3)N=C(C=C2)C2=CN=C(C)C=C2)C(=O)N1 References General References Not Available External Links PubChem Compound 44631903 PubChem Substance 99443901 ChemSpider 25058556 BindingDB 50395272 ChEMBL CHEMBL1231206 ZINC ZINC000039258365 PDBe Ligand B97 PDB Entries 3fyj  /  6t8x  /  7nry Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.00153 mg/mL ALOGPS logP 3.86 ALOGPS logP 3.53 Chemaxon logS -5.4 ALOGPS pKa (Strongest Acidic) 15.79 Chemaxon pKa (Strongest Basic) 5 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 66.91 Å 2 Chemaxon Rotatable Bond Count 1 Chemaxon Refractivity 106.92 m 3 ·mol -1 Chemaxon Polarizability 41.3 Å 3 Chemaxon Number of Rings 5 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9964 Blood Brain Barrier + 0.9272 Caco-2 permeable - 0.5609 P-glycoprotein substrate Substrate 0.671 P-glycoprotein inhibitor I Non-inhibitor 0.7103 P-glycoprotein inhibitor II Non-inhibitor 0.9621 Renal organic cation transporter Non-inhibitor 0.8144 CYP450 2C9 substrate Non-substrate 0.7342 CYP450 2D6 substrate Non-substrate 0.7749 CYP450 3A4 substrate Substrate 0.6195 CYP450 1A2 substrate Inhibitor 0.8217 CYP450 2C9 inhibitor Non-inhibitor 0.5606 CYP450 2D6 inhibitor Non-inhibitor 0.7565 CYP450 2C19 inhibitor Inhibitor 0.6308 CYP450 3A4 inhibitor Non-inhibitor 0.6672 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.6697 Ames test Non AMES toxic 0.6855 Carcinogenicity Non-carcinogens 0.876 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.3178 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9987 hERG inhibition (predictor II) Inhibitor 0.5791    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more Binding Properties × Property Measurement pH Temperature (°C) References IC 50 (nM) 5 N/A N/A A29807 
 
 
  Details 
 
 
   Binding Properties 1.  MAP kinase-activated protein kinase 2 Kind Protein Organism Humans Pharmacological action Unknown General Function Signal transducer activity Specific Function Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling, DNA dam... Gene Name MAPKAPK2 Uniprot ID P49137 Uniprot Name MAP kinase-activated protein kinase 2 Molecular Weight 45567.415 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:21 / Updated at June 12, 2020 16:52 